Myoseverin
Myoseverin is a microtubule-binding molecule and angiogenesis inhibitor. Myoseverin can induce the reversible fission of multinucleated myotubes into mononucleated fragments. In addition, Myoseverin exerts anti-angiogenic effects by inhibiting endothelial cell function and endothelial progenitor cell differentiation[1][2].
Product Specifications
CAS Number
[267402-71-1]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
DNA/RNA Synthesis; Microtubule/Tubulin
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton
Applications
COVID-19-anti-virus
Field of Research
Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/myoseverin.html
Purity
99.42
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
CC(N1C=NC2=C(NCC3=CC=C(OC)C=C3)N=C(NCC4=CC=C(OC)C=C4)N=C12)C
Molecular Formula
C24H28N6O2
Molecular Weight
432.52
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog
FCER1G (NM_004106) Human Over-expression Lysate
GFR alpha1, IN (GDNFRa, Glial Cell-derived Neurotrophic Factor Receptor a1, RETL1, Ret ligand 1, TGFb-related Neurotrophic Factor Receptor 1, TrnR1, Glycosylphosphadidylinositol linked Protein) (PE)
HTR3B (5-hydroxytryptamine Receptor 3B, 5-hydroxytryptamine (Serotonin) Receptor 3B, Ionotropic)
Lentiviral human POLR3GL sgRNA gene knockout kit - Lentiviral human POLR3GL sgRNA gene knockout kit (plasmid)
